Table 1.
Demographic information and liver function of study population.
| Control group (n = 78) | HBV-IaC (n = 28) | CHB (n = 48) | CHC (n = 30) | DHC (n = 55) | HCC (n = 116) | ||
|---|---|---|---|---|---|---|---|
| Gender (male/female) | 58/20 | 19/9 | 34/14 | 24/6 | 47/8 | 60/26 | |
| Age (years) | 37(17)# | 35(33)# | 41.69 ± 10.39* | 43.5(12)# | 47.36 ± 14.21* | 56.5(13)# | |
| HBsAg (negative/positive) | Negative | Positive | Positive | Positive | Positive | Positive | |
| ALT(U/L) (3–50) | 12.1 ± 2.73* | 22.75(10.75)# | 126.4(147.3)# | 24.2(18.05)# | 39.4(40)# | 54.22 ± 23.29* | |
| AST(U/L) (3–50) | 16(11.75)# | 18.9(11.57)# | 45(64.5)# | 50.86 ± 23.67* | 19(17)# | 34.05(31.8)# | |
| TB (umol/L) (1–22) | 8(5.25)# | 8(9.5)# | 21(19)# | 25.05 ± 6.93* | 24(13)# | 24.5(18.75)# | |
| ALB (g/L) (35–55) | 46(3)# | 45.5(4.5)# | 41.77 ± 4.03* | 39 ± 3.69* | 29(7)# | 34(5)# | |
| PT(s) (10.5–14.0) | – | 11.6(1.08)2 | 11.73 ± 0.731 | 12.56 ± 0.811 | 15.6(3.1)2 | 13.5(2.95)2 | |
*Data as normal, described as: mean +/−standard deviation, P > 0.1; #data for the non-normal, described as: the median (interquartile range), P < 0.1;– : not to do.